Preview

Russian Journal of Cardiology

Advanced search

CLINICAL EFFECTIVENESS OF EARLY ACUTE MYOCARDIAL INFARCTION DIAGNOSTICS, BASED ON THE ASSESSMENT OF CARDIAC FATTY ACID BINDING PROTEIN LEVELS

Abstract

Aim. To investigate the diagnostic potential of cardiac fatty acid binding protein (cFABP) vs. cardiac troponins at the early stages of acute coronary syndrome (ACS), by comparing specificity and sensitivity of the qualitative assessment of their blood levels. Material and methods. The independent Russian multi-centre study ISPOLIN (Clinical effectiveness of early acute myocardial infarction diagnostics, based on the assessment of cFABP levels) included 1049 patients, who were hospitalised with possible ACS diagnosis, within 1–12 hours from the clinical onset. At admission, all participants underwent a qualitative assessment of cFABP and troponin I (TrI) blood levels. For each test, sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) were examined for the whole sample, as well as by gender, age, body mass index (BMI), test time, and electrocardiographic (ECG) changes. Results. The sensitivity of cFABP test was higher than that for TrI (73,8% vs. 46,7%, respectively). Specificity reached 92% and 97,2%, respectively. Respective accuracy values were 79,3% and 62,2%. PPV was 0,95 for cFABP and 0,97 for TrI, while NPV was 0,61 and 0,45, respectively. The maximal sensitivity of cFABP test was observed within 3–6 hours from the onset of acute myocardial infarction, and exceeded the sensitivity of TrI test by 18–32% at all examined time points. Regardless of the ECG change type, sensitivity of cFABP test was higher than that of TrI test by 19–73%. For both tests, sensitivity and specificity did not correlate with age, gender, or BMI. Conclusion. Within the first 12 hours from the clinical onset of possible ACS, a Russian express test, which qualitatively assesses cFABP levels, demonstrated higher sensitivity, accuracy, and NPV, compared to the TrI test. The cFABP test can, therefore, be recommended for a wider use in clinical practice.

About the Authors

A. I. Martynov
Russian Scientific Medical Society of Internal Medicine, Russia
Russian Federation


M. I. Voevoda
Russian Scientific Medical Society of Internal Medicine, Russia
Russian Federation


G. P. Arutyunov
Russian Scientific Medical Society of Internal Medicine, Russia
Russian Federation


V. A. Kokorin
Russian Scientific Medical Society of Internal Medicine, Russia
Russian Federation


A. A. Spasskyi
Russian Scientific Medical Society of Internal Medicine, Russia
Russian Federation


References

1. National guidelines on diagnosis and treatment of acute myocardial infarction in patients presenting with ST-segment elevation. Cardiovascular therapy and prevention 2007; 6 (8), Appendix 1:415–500. Russian (Национальные рекомендации по диагностике и лечению больных острым инфарктом миокарда с подъемом сегмента ST ЭКГ. Кардиоваскулярная терапия и профилактика 2007; 6 (8), Приложение 1:415–500).

2. Wu A.H.B., Feng Y.J., Contois J.H. et al. Comparison of myoglobin, creatine kinase-MB and cardiac troponin I for diagnosis of acute myocardial infarction. Ann Clin Lab Sci 1996; 26:291–300.

3. Kleine A.H., Glatz J.F., van Nieuwenhoven F.A. et al. Release of heart fatty acid-binding protein after acute myocardial infarction in man. Mol Cell Biochem 1992; 116:155–162.

4. Glatz J.F., van Bilsen M., Paulusaen R. et al. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 1988; 961:1:148–152.

5. McCann C.J., Glover B.M., Menown I.B. et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. European Heart Journal 2008; 29 (23):2843–2850.

6. Nakata T., Hashimoto A., Hase M. et al. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology 2003; 99:96–104.

7. O’Donoghue M., de Lemos J.A., Morrow D.A. et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 2006; 114:550–557.

8. Seino Y., Ogata K. et al. Use of a whole blood rapid panel test for heart-type fatty acidbinding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am J Med 2003; 115:185–190.

9. Chelobanov B.P., Afinogenova G.N., Cheshenko I.O. et al. Analytical characteristics of express-tests for immunochromatographic analysis. Laboratory 2010; 2:17–18. Russian (Челобанов Б.П., Афиногенова Г.Н., Чешенко И.О. и др. Аналитические характеристики экспресс-тестов для иммунохроматографического анализа. Лаборатория 2010; 2:17–18).

10. Alhashemi J.A. Diagnostic accuracy of a bedside qualitative immunochromatographic test for acute myocardial infarction. Am J Emergency Med 2006; 24:149–155.

11. Gilarevsky S. R., Baturina O. V., Larin A. G. et al. The efficacy of usage of express-test for the qualitative determination of the level of fatty acid binding protein in the blood for the diagnosis of myocardial infarction in early terms after the development of its clinical manifestations. Materials of the Russian national congress of cardiologists, Moscow 2011; 75. Russian (Гиляревский С. Р., Батурина О. В., Ларин А. Г. и др. Эффективность использования экспресс-теста для качественного определения уровня белка, связывающего жирные кислоты, в крови для диагностики инфаркта миокарда в ранние сроки после развития его клинических проявлений. Материалы Российского национального конгресса кардиологов, Москва 2011; 75).

12. Golovenkin S. E., Shulman V. A., Pelipetskaya E. Y. et al. Possibilities of express-test “CardioFABP” in the diagnosis of acute myocardial infarction. The emergency doctor 2011; 11:25–30. Russian (Головенкин С. Е., Шульман В. А., Пелипецкая Е.Ю. и др. Возможности экспресс-теста «КардиоБСЖК» при диагностике острого инфаркта миокарда. Врач скорой помощи 2011; 11:25–30).

13. Zyryanova A. V., Yarokhno N. N., Nikolaev K. Y. The effectiveness of immuno chromatographic method for determining of the heart fatty acid binding protein in the early differential diagnosis of acute coronary syndrome. Pathology of the blood circulation and cardiac surgery 2010; 4:12–16. Russian (Зырянова А.В., Ярохно Н. Н., Николаев К.Ю. Эффективность иммунохроматографического метода определения сердечного белка, связывающего жирные кислоты, при ранней дифференциальной диагностике острого коронарного синдрома. Патология кровообращения и кардиохирургия 2010; 4:12–16).

14. Kalinichenko R. M., Syrkin A. L., Kopylov F. Y. The usage of immunochromatographic method of determining FABP in the differential diagnosis of myocardial infarction and unstable angina. Materials of the Congress “Man and medicine”, Moscow 2011; 62. Russian (Калиниченко Р. М., Сыркин А. Л., Копылов Ф.Ю. Применение иммунохроматографического метода определения БСЖК в дифференциальной диагностике инфаркта миокарда и нестабильной стенокардии. Материалы Конгресса «Человек и лекарство», Москва 2011; 62).

15. Ryabov V. V., Suslova T. E., Maksimov A. I. et al. Determination of protein binding fatty acids in the diagnosis of myocardial infarction: the experience of the Scientific Research Institute of cardiology. Cardioangiology and rheumatology 2010; 1 (2):17– 21. Russian (Рябов В.В., Суслова Т. Е., Максимов А. И. и др. Определение белка -переносчика жирных кислот в диагностике инфаркта миокарда: опыт НИИ кардиологии. Кардиоангиология и ревматология 2010; 1 (2):17–21).


Review

For citations:


Martynov A.I., Voevoda M.I., Arutyunov G.P., Kokorin V.A., Spasskyi A.A. CLINICAL EFFECTIVENESS OF EARLY ACUTE MYOCARDIAL INFARCTION DIAGNOSTICS, BASED ON THE ASSESSMENT OF CARDIAC FATTY ACID BINDING PROTEIN LEVELS. Russian Journal of Cardiology. 2012;(3):7-11. (In Russ.)

Views: 893


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)